Vitamin D Series Compounds
| Product Name | CAS No. | Specification | Application | Registration |
| 24, 25-Dihydroxy VD3 | 40013-87-4 | 98+% | A vitamin D3 metabolite with potential in calcium regulation and bone health research | |
| Maxacalcitol (22-Oxacalcitriol) | 103909-75-7 | 99+% | A VDR agonist, is used in psoriasis and hyperparathyroidism research. | |
| Doxercalciferol | 54573-75-0 | 99+% | A VD2 analog, activates VDR, prevents renal disease. | |
| Ercalcidiol | 21343-40-8 | 98+% | A vitamin D2 metabolite, assesses vitamin D levels. | |
| Ercalcitriol (1α,25-Dihydroxyvitamin D2) | 60133-18-8 | 98+% | A Vitamin D2 metabolite, targets VDR in research. | |
| Vitamin D4 | 511-28-4 | 98+% | VD/VDR agonist, |
Products
- All
- Pharmaceutical Intermediates
- Active Pharmaceutical Ingredients
- Anti-Cancer (Oncology)
- Vitamin D Series Compounds
- Antibody-Drug Conjugates
- Prostaglandins
- Immunosuppressants
- Cardiovascular
- Antiviral Agents
- Anti-Diabetic
- Peptides
- Veterinary
- Antibacterial
- Miscellaneous
- Drug Impurities & Metabolites
- Novel Life Science Reagents
- Amino Acids & Vitamins
- Natural Products
- Health & Nutritional Ingredients
- Pharmaceutical Excipients
- Specialty Chemicals & Building Blocks
Custom Synthesis-High Value-Added Advanced Pharmaceutical Intermediates
E-Mail: sales (at)Chemleader.com.cn
E-Mail: sales (at)Chemleader.com.cn